CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Protek PAO Company Snapshot
Protek PAO operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Protek PAO with three other pharmaceutical manufacturers in Europe: UCB Sa of Belgium (2016 sales of 4.18 billion Euro [US$4.81 billion] of which 100% was Biopharmacy), Stada Arzneimittel AG of Germany (2.14 billion Euro [US$2.46 billion] of which 60% was Generics), and Lonza Group AG which is based in Switzerland (4.13 billion Swiss Francs [US$4.32 billion] of which 54% was Specialty Ingredients).

Sales Analysis. During the year ended December of 2016, sales at Protek PAO were 241.48 billion Russian Rubles (US$4.09 billion). This is an increase of 23.6% versus 2015, when the company's sales were 195.31 billion Russian Rubles. This was the fifth consecutive year of sales increases at Protek PAO (and since 2011, sales have increased a total of 126%). Sales of Retail Sales saw an increase of 32.2% in 2016, from 30.07 billion Russian Rubles to 39.76 billion Russian Rubles. Not all segments of Protek PAO experienced an increase in sales in 2016: sales of Production fell 6.4% to 5.90 billion Russian Rubles. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Protek PAO
  Stock Performance Chart for Protek PAO
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 101.40
(Figures in Russian Rubles)
1 Week 1.1%   13 Weeks 4.1%  
4 Weeks 1.4%   52 Weeks 24.1%  
 
Protek PAO Key Data:
  Ticker: PRTK Country: Russian Federation
  Exchanges: RTS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 241,481,755,000
(Year Ending Jan 2017).
Employees: 13,700
  Currency: Russian Rubles Market Cap: 53,452,285,700
  Fiscal Yr Ends: December Shares Outstanding: 527,142,857
  Share Type: Closely Held Shares: 438,643,478
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.